Cannasat Therapeutics Inc. Announces New Director and Releases Q1 2006 Financial Statements
Canada Newswire, June 5, 2022
June 5, 2022 - Toronto, Ontario - Cannasat Therapeutics Inc. (CTH - TSXV) ("Cannasat") is pleased to announce the addition of Peter Palframan to the Board of Directors. Peter will also serve as the Chairman of Cannasat's Audit Committee. He replaces David Hill who remains as Cannasat's Chief Executive Officer.
Peter Palframan is a Chartered Accountant and currently the Senior Vice President of Operations at CHUM Television. Peter was previously Vice President, Finance & Administration, CHUM Television and Vice President, Finance and Operations of Learning and Skills Television of Alberta. Peter has been in the television broadcasting industry for over 20 years and assisted in negotiations that resulted in the privatization and acquisition of the provincial educational service, Access TV, and played a major role in the launch of Canadian Learning Television (CLT), BookTelevision and CourtTV Canada. He was a key player in the team behind the purchase of Craig Media and the integration of the new station assets.
"Peter has a history of operational excellence and leadership working with some of the most reputable companies in the television broadcasting industry. His expertise in accounting, management systems, and corporate finance, will be an enormous asset to the Cannasat Board of Directors and Audit Committee", said Moses Znaimer, Chairman of Cannasat.
About Cannasat Therapeutics
Cannasat is researching the therapeutic benefits of cannabis and developing new cannabinoid pharmaceutical products. Cannasat is pursuing two complementary business strategies. The first consists of development of novel cannabinoid-based pharmaceutical products through application of drug delivery technologies to be introduced to the market through the traditional regulatory drug approval process. The second is to promote medicinal cannabis research and education with Cannasat's business partner, Prairie Plant Systems Inc., the only government licensed grower and distributor of medicinal cannabis in Canada.
For more information please contact:
Cannasat Therapeutics Inc.
Andrew Williams
Vice President, Operations
W: (416) 703-2449 (Ext. 253)
F: (416) 703-8752
[email protected]
www.cannasat.com
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this release.
Top of Page
